Primecap Management CO Mereo Biopharma Group PLC Transaction History

Primecap Management CO

$134 Billion
Q3 2024

A detailed history of Primecap Management CO transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Primecap Management CO holds 54,000 shares of MREO stock, worth $163,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,000

Previous 54,000 -0.0%

Holding current value

$163,620

Previous $194,000 13.92%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$1.19 - $2.42 $29,750 - $60,500	-25,000 Reduced 31.65%	54,000 $124,000
Q3 2023 Nov 13, 2023	SELL	$1.15 - $1.67 $90,505 - $131,429	-78,700 Reduced 49.9%	79,000 $101,000
Q2 2023 Aug 11, 2023	SELL	$0.79 - $1.43 $109,675 - $198,526	-138,830 Reduced 46.82%	157,700 $208,000
Q1 2023 May 15, 2023	SELL	$0.71 - $1.22 $497 - $854	-700 Reduced 0.24%	296,530 $210,000
Q4 2022 Feb 13, 2023	SELL	$0.5 - $1.01 $8,765 - $17,705	-17,530 Reduced 5.57%	297,230 $222,000
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.73 $5,658 - $11,937	-6,900 Reduced 2.15%	314,760 $271,000
Q2 2022 Aug 11, 2022	SELL	$0.33 - $1.69 $3,049 - $15,615	-9,240 Reduced 2.79%	321,660 $360,000
Q1 2022 May 11, 2022	SELL	$1.04 - $1.7 $1,352 - $2,210	-1,300 Reduced 0.39%	330,900 $371,000
Q4 2021 Feb 11, 2022	SELL	$1.51 - $2.59 $11,174 - $19,166	-7,400 Reduced 2.18%	332,200 $532,000
Q3 2021 Nov 12, 2021	SELL	$2.2 - $3.17 $328,543 - $473,401	-149,338 Reduced 30.54%	339,600 $822,000
Q2 2021 Aug 10, 2021	SELL	$2.94 - $4.08 $476 - $660	-162 Reduced 0.03%	488,938 $1.55 Million
Q2 2020 Aug 13, 2020	SELL	$1.0 - $3.4 $54,275 - $184,535	-54,275 Reduced 9.99%	489,100 $1.5 Million
Q1 2020 May 14, 2020	SELL	$0.8 - $3.21 $46,709 - $187,422	-58,387 Reduced 9.7%	543,375 $560,000
Q4 2019 Feb 14, 2020	SELL	$1.1 - $3.7 $89,753 - $301,897	-81,594 Reduced 11.94%	601,762 $1.97 Million
Q3 2019 Nov 13, 2019	SELL	$2.22 - $4.14 $28,313 - $52,801	-12,754 Reduced 1.83%	683,356 $1.98 Million
Q2 2019 Aug 14, 2019	BUY	$2.52 - $6.5 $1.75 Million - $4.52 Million	696,110 New	696,110 $1.67 Million

Others Institutions Holding MREO

# of Institutions

Shares Held

107M

Call Options Held

209K

Put Options Held

479K

View Full List

About Mereo Biopharma Group plc

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $379M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

More about MREO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Mereo Biopharma Group PLC Transaction History